Climb Bio Stock Today
| CLYM Stock | 1.27 0.03 2.31% |
PerformanceVery Weak
| Odds Of DistressHigh
|
Climb Bio is selling at 1.27 as of the 27th of March 2025; that is 2.31 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.25. Climb Bio has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Climb Bio symbol was changed from ELYM on 3rd of October 2024. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 27th of March 2025. Click here to learn more.
IPO Date 10th of August 2021 | Category Healthcare |
Climb Bio is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 67 M outstanding shares of which 1.9 M shares are currently shorted by private and institutional investors with about 0.0 trading days to cover. More on Climb Bio
Moving together with Climb Stock
Moving against Climb Stock
Climb Stock Highlights
| Older Symbol | ELYM | |||||||||||||||||||||||||||||||||||
| President CEO | BAO BCh | |||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, NASDAQ Health Care, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Climb Bio (CLYM) is traded on NASDAQ Exchange in USA. It is located in PMB #117, 2801 Centerville Road, Wilmington, DE, United States, 19808-1609 and employs 10 people. Climb Bio was previously known as ELYM Old and was traded on NASDAQ Exchange under the symbol ELYM. Climb Bio is listed under Pharmaceutical Products category by Fama And French industry classification. The company conducts business under Healthcare sector and is part of Biotechnology industry. Climb Bio has 67 M outstanding shares of which 1.9 M shares are currently shorted by private and institutional investors with about 0.0 trading days to cover.
Climb Bio generates negative cash flow from operations
Check Climb Bio Probability Of Bankruptcy
Climb Bio Historical Income Statement
Climb Stock Against Markets
Climb Bio Corporate Management
| Janaki MSc | VP Affairs | Profile | |
| Jo PalmerPhillips | Chief Officer | Profile | |
| Perrin BS | Chief Officer | Profile | |
| Emily CPA | Senior Officer | Profile | |
| Kate MBA | Senior Management | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.